Two Sigma Investments’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$244K Buy
32,931
+30,785
+1,435% +$228K ﹤0.01% 2811
2025
Q1
$18.5K Sell
2,146
-6,289
-75% -$54.1K ﹤0.01% 3048
2024
Q4
$302K Sell
8,435
-3,574
-30% -$128K ﹤0.01% 2669
2024
Q3
$567K Sell
12,009
-17,939
-60% -$848K ﹤0.01% 2346
2024
Q2
$1.5M Buy
29,948
+21,230
+244% +$1.07M ﹤0.01% 1679
2024
Q1
$976K Buy
8,718
+1,864
+27% +$209K ﹤0.01% 1911
2023
Q4
$398K Buy
6,854
+891
+15% +$51.7K ﹤0.01% 2489
2023
Q3
$189K Sell
5,963
-4,728
-44% -$150K ﹤0.01% 2576
2023
Q2
$879K Buy
10,691
+2,508
+31% +$206K ﹤0.01% 1938
2023
Q1
$841K Sell
8,183
-16,530
-67% -$1.7M ﹤0.01% 1885
2022
Q4
$3.62M Sell
24,713
-2,570
-9% -$377K 0.01% 976
2022
Q3
$4.61M Buy
27,283
+9,236
+51% +$1.56M 0.02% 763
2022
Q2
$2.08M Sell
18,047
-32,978
-65% -$3.81M 0.01% 1138
2022
Q1
$5.09M Buy
51,025
+15,915
+45% +$1.59M 0.02% 896
2021
Q4
$5.46M Buy
35,110
+21,180
+152% +$3.29M 0.01% 876
2021
Q3
$3.28M Sell
13,930
-8,631
-38% -$2.03M 0.01% 1102
2021
Q2
$7.66M Buy
22,561
+7,138
+46% +$2.42M 0.02% 747
2021
Q1
$6.24M Buy
15,423
+7,490
+94% +$3.03M 0.02% 742
2020
Q4
$5.28M Buy
7,933
+1,222
+18% +$813K 0.02% 713
2020
Q3
$3.12M Sell
6,711
-2,064
-24% -$961K 0.01% 769
2020
Q2
$5.13M Buy
8,775
+5,727
+188% +$3.35M 0.03% 528
2020
Q1
$444K Buy
3,048
+1,820
+148% +$265K ﹤0.01% 1298
2019
Q4
$176K Sell
1,228
-3,438
-74% -$493K ﹤0.01% 1998
2019
Q3
$184K Buy
4,666
+3,481
+294% +$137K ﹤0.01% 1768
2019
Q2
$120K Sell
1,185
-1,567
-57% -$159K ﹤0.01% 1921
2019
Q1
$362K Buy
2,752
+35
+1% +$4.6K ﹤0.01% 1763
2018
Q4
$277K Buy
+2,717
New +$277K ﹤0.01% 1772